Clinical Trials
Mezigdomide, Carfilzomib, and Dex vs. Carfilzomib and Dex in participants with MM
Disease Type: Myelomas
A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide (CC-92480/BMS-986348), Carfilzomib, and Dexamethasone (MeziKd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM):SUCCESSOR-2 (CA057008)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville